Target intelligence / Profile preview

Gram-negative bacterial outer membrane lipid A and anionic phospholipids (Lipid A / Anionic Phospholipids)

Target
Lipid A / Anionic Phospholipids
Molecular classification
Lipid, Glycolipid, Bacterial cell envelope component
01

Overview

Lipid A is the highly conserved, hydrophobic anchor of lipopolysaccharide (LPS) located in the outer leaflet of the Gram-negative bacterial outer membrane. It serves as a critical structural component and a potent endotoxin that triggers the host innate immune response through the TLR4/MD-2 receptor complex. Anionic phospholipids, such as phosphatidylglycerol, further contribute to the overall negative charge of the bacterial surface. These molecules are primary therapeutic targets for polymyxin-class antibiotics, which utilize electrostatic interactions to disrupt membrane stability. Because lipid A is essential for the viability of most Gram-negative pathogens, it remains a focal point for developing novel treatments against multidrug-resistant infections, including those caused by Pseudomonas aeruginosa and Acinetobacter baumannii.

Other names
Lipid AEndotoxin anchorBacterial outer membrane phospholipidsLipopolysaccharide lipid A componentAnionic bacterial membrane lipids
02

Mechanism of action

Cationic cyclic peptides bind electrostatically to the negatively charged phosphate groups of lipid A and anionic phospholipids, displacing divalent cations (Ca2+ and Mg2+), which destabilizes the outer membrane and leads to increased permeability, cytoplasmic leakage, and cell death.

03

Biological functions

Structural integrity of the outer membranePermeability barrierEndotoxic activityActivation of the innate immune system via TLR4Anchoring of lipopolysaccharides
04

Disease associations

Gram-negative bacterial infectionSepsisSeptic shockMultidrug-resistant bacterial infections
05

Safety considerations

NephrotoxicityNeurotoxicityRelease of endotoxins during rapid bacterial lysis leading to Jarisch-Herxheimer-like reactionsEmergence of resistance via lipid A modification (e.g., mcr-1 gene)
06

Interacting drugs

Colistin (Polymyxin E)

5 more in the full profile.

07

Biomarkers

Endotoxin levels (LAL assay)Procalcitonin (infection marker)C-reactive proteinBacterial load (CFU/mL)

Beyond the preview

Go deeper on Gram-negative bacterial outer membrane lipid A and anionic phospholipids (Lipid A / Anionic Phospholipids).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacterial outer membrane lipid A and anionic phospholipids (Lipid A / Anionic Phospholipids).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call